智通财经APP获悉，天风证券发布研究报告称，维持信达生物(01801)“买入”评级，考虑到公司已上市产品持续放量，多条研发管线即将进入产品收获期，将2024和2025年的收入预期分别从72.25、91.93亿元上调至79.70、102.35亿元，预计 ...

a recombinant anti-IGF-1R monoclonal antibody. Additionally, it distributes pharmaceutical products; and provides consultation, and research and development services. Innovent Biologics ...

【解剖大盘】A股终于开盘，经过国庆的发酵，开盘即出现井喷。沪指高开10.13%，达到3674.4点，创业板指高开幅度高达18.44%。成交量首次突破三万亿，达到3.45万亿的历史巨量，上涨股票超5000只，市场呈现一片牛市欣欣向荣景象。而港股这边画风 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

GLP-1 receptor agonists are a non-insulin type 2 diabetes medication. GLP-1 agonists help to lower blood sugar and aid in weight loss. Drugs in this class include Byetta (exenatide), Victoza ...

Get your thinking caps on for another brainteaser from Mollie!

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver disease globally and is currently estimated to affect up to 38% of the global adult population. NAFLD is a ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...